Searches , social queries for EUDRACT
Search references for EUDRACT. Phrases containing EUDRACT
See searches and references containing EUDRACT!
Search references for EUDRACT. Phrases containing EUDRACT
See searches and references containing EUDRACT!EUDRACT
European clinical trials registry
EudraCT (European Union Drug Regulating Authorities Clinical Trials) is the European clinical trials database of all clinical trials of investigational
EudraCT
relevant information to industry, scientific experts and regulators. eHealth EudraCT EudraGMP EudraPharm EudraVigilance European Medicines Agency Qualified
EUDRANET
Agency of the European Union
central set of pan-European systems and databases such as EudraVigilance, EudraCT and EudraPharm. The centralised procedure allows companies to submit a
European_Medicines_Agency
have to adverse drug reactions reports. Clinical trial Drug development EudraCT EudraGMP EudraLex EUDRANET EudraPharm European Medicines Agency International
EudraVigilance
nCoV-19". EU Clinical Trials Register. European Union. 21 April 2020. EudraCT 2020-001228-32. Archived from the original on 5 October 2020. Retrieved
List of COVID-19 vaccine authorizations
List_of_COVID-19_vaccine_authorizations
Viral vector vaccine for prevention of COVID-19
EU Clinical Trials Register (Registry). European Union. 21 April 2020. EudraCT 2020-001228-32. Archived from the original on 5 October 2020. Retrieved
Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca_COVID-19_vaccine
US government registry of clinical trials
Technical Document Ethical problems using children in clinical trials EudraCT European Medicines Agency FDA Special Protocol Assessment International
ClinicalTrials.gov
Chemical compound
NCT02378480 for "Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)" at ClinicalTrials.gov "Paratek Announces that Omadacycline
Omadacycline
of the most recent GMP inspection.” European Medicines Agency EUDRANET EudraCT EudraPharm EudraVigilance GxP EudraGMP.EMA. 2007. Web November 13, 2013
EudraGMP
Pharmaceutical compound
antihistamine pathways. A Phase 2 proof-of-concept trial (NCT03110458 / EudraCT 2016–003927–45) of seliforant in acute unilateral vestibulopathy was completed
Seliforant
Vaccine against SARS-CoV-2
Regimens in Healthy Adults". EU Clinical Trials Register. 14 April 2020. EudraCT 2020-001038-36. Archived from the original on 22 April 2020. Retrieved
COVID-19_vaccine
via the EPARs section at the EMEA. European Medicines Agency EUDRANET EudraCT EudraGMP EudraVigilance "EudraPharm | European Medicines Agency (EMA)"
EudraPharm
Dutch psychiatrist
Simvastatin augmentation for recent onset schizophrenia PI 2013-2020 EudraCT 2015-003503-39 Stanley Foundation. Omega fatty aids Trial in Ultra High
René_Kahn
Chemical compound
Ferrer reported on 10 January 2024 that the phase III ADORE clinical trial (EudraCT 2020-003376-40/NCT05178810) of FAB122/TW001 fo4 ALS did not meet the primary
Edaravone
EU Clinical Trials Register (Registry). European Union. 21 April 2020. EudraCT 2020-001228-32. Retrieved 3 August 2020. O'Reilly, Peter (26 May 2020)
COVID-19 pandemic in Argentina
COVID-19_pandemic_in_Argentina
Pharmaceutical compound
patients. A randomised, double-blind, placebo-controlled Phase IIa study (EudraCT 2014–002179–27) titled "QUIET-1" enrolled participants with subjective
AUT-00063
Type of vaccine
nCoV-19". EU Clinical Trials Register. European Union. 21 April 2020. EudraCT 2020-001228-32. Archived from the original on 5 October 2020. Retrieved
Viral_vector_vaccine
Swedish biopharmaceutical company
trial, conducted at Örebro University Hospital in Sweden and registered as EudraCT 2020-002078-29 (NCT04896853), completed patient treatment in February 2025
Nextcell_Pharma_AB
Chemical compound used in cancer therapy
investigational treatment for patients in the EMR 63325-009 study in Japan. EudraCT: 2011-004822-85 A prospective, open, randomized, phase-II study of a therapeutic
Tecemotide
Danish cancer treatment working group
for recurrent and or metastatic head and neck squamous cell carcinoma.EudraCT 2014-001023-80 DAHANCA 28 (2013-2019, 50 patients ) Phase I/II study of
DAHANCA
Murine monoclonal antibody against CD37
651–61. doi:10.1517/14712598.2014.890182. PMID 24555705. S2CID 19987961. "EudraCT Number: 2011-000033-36". EU Clinical Trials Registry. Treatment of lymphoma
Lilotomab
clinical registry is the RPCEC (Cuban Public Registry of Clinical Trials). EudraCT is a database of all clinical trials conducted in the European Union since
List of clinical trial registries
List_of_clinical_trial_registries
Marketing research
European Medicines Agency mandates registration and results reporting through EudraCT, while systems in low- and middle-income countries often remain less stringent
Seeding_trial
TKI inhibitor used for cancer treatment
clinical trials of 355 patients with various types of solid tumors: Trial 1 (EudraCT 2012-000148-88), Trial 2 (NCT02097810), Trial 3 (NCT02568267), and Trial
Entrectinib
Australian biotechnology company
of Medicine (U.S.). 20 March 2022. NCT05298306. Retrieved 13 May 2026. "EudraCT Number 2018-004534-15 - Clinical trial results". EU Clinical Trials Register
Lateral_Pharma
Chemical compound
released the results of their Phase II study (identification: NCT01384422, Eudract: 2010-022953-40) in which 36 rheumatoid arthritis patients were treated
Filgotinib
travel, tourism, insurance
EUDRACT
EUDRACT
EUDRACT
EUDRACT
EUDRACT
EUDRACT
EUDRACT
EUDRACT
EUDRACT
travel, tourism, insurance